Atypical antipsychotic drugs and the risk for acute kidney injury and other adverse outcomes in older adults: a population-based cohort study
- PMID: 25133360
- DOI: 10.7326/M13-2796
Atypical antipsychotic drugs and the risk for acute kidney injury and other adverse outcomes in older adults: a population-based cohort study
Abstract
Background: Several adverse outcomes attributed to atypical antipsychotic drugs, specifically quetiapine, risperidone, and olanzapine, are known to cause acute kidney injury (AKI). Such outcomes include hypotension, acute urinary retention, and the neuroleptic malignant syndrome or rhabdomyolysis.
Objective: To investigate the risk for AKI and other adverse outcomes associated with use of atypical antipsychotic drugs versus nonuse.
Design: Population-based cohort study.
Setting: Ontario, Canada, from 2003 to 2012.
Patients: Adults aged 65 years or older who received a new outpatient prescription for an oral atypical antipsychotic drug (n=97,777) matched 1:1 with those who did not receive such a prescription.
Measurements: The primary outcome was hospitalization with AKI (assessed by using a hospital diagnosis code and, in a subpopulation, serum creatinine levels) within 90 days of prescription for atypical antipsychotic drugs.
Results: Atypical antipsychotic drug use versus nonuse was associated with a higher risk for hospitalization with AKI (relative risk [RR], 1.73 [95% CI, 1.55 to 1.92]). This association was consistent when AKI was assessed in a subpopulation for which information on serum creatinine levels was available (5.46% vs. 3.34%; RR, 1.70 [CI, 1.22 to 2.38]; absolute risk increase, 2.12% [CI, 0.80% to 3.43%]). Drug use was also associated with hypotension (RR, 1.91 [CI, 1.60 to 2.28]), acute urinary retention (RR, 1.98 [CI, 1.63 to 2.40]), and all-cause mortality (RR, 2.39 [CI, 2.28 to 2.50]).
Limitation: Only older adults were included in the study.
Conclusion: Atypical antipsychotic drug use is associated with an increased risk for AKI and other adverse outcomes that may explain the observed association with AKI. The findings support current safety concerns about the use of these drugs in older adults.
Primary funding source: Academic Medical Organization of Southwestern Ontario.
Comment in
-
ACP Journal Club: new use of atypical antipsychotics was linked to acute kidney injury and all-cause mortality at 90 days.Ann Intern Med. 2015 Feb 17;162(4):JC12. doi: 10.7326/ACPJC-2015-162-4-012. Ann Intern Med. 2015. PMID: 25686187 No abstract available.
-
Acute kidney injury and mortality in the elderly: add atypical antipsychotics to the list.Am J Kidney Dis. 2015 May;65(5):655-8. doi: 10.1053/j.ajkd.2015.01.005. Epub 2015 Feb 14. Am J Kidney Dis. 2015. PMID: 25687262 No abstract available.
-
New use of antipsychotics associated with a small increased risk of acute kidney injury in older adults with mental disorders.Evid Based Ment Health. 2015 May;18(2):55. doi: 10.1136/eb-2014-101979. Epub 2015 Mar 5. Evid Based Ment Health. 2015. PMID: 25743449 Free PMC article. No abstract available.
Similar articles
-
A Retrospective Cohort Study of Acute Kidney Injury Risk Associated with Antipsychotics.CNS Drugs. 2017 Apr;31(4):319-326. doi: 10.1007/s40263-017-0421-4. CNS Drugs. 2017. PMID: 28290080
-
Risk of falls and fractures in older adults using atypical antipsychotic agents: a propensity score-adjusted, retrospective cohort study.Am J Geriatr Pharmacother. 2012 Apr;10(2):83-94. doi: 10.1016/j.amjopharm.2011.10.006. Epub 2012 Feb 10. Am J Geriatr Pharmacother. 2012. PMID: 22306198
-
Risk of acute kidney injury from oral acyclovir: a population-based study.Am J Kidney Dis. 2013 May;61(5):723-9. doi: 10.1053/j.ajkd.2012.12.008. Epub 2013 Jan 10. Am J Kidney Dis. 2013. PMID: 23312723 Clinical Trial.
-
An open, large, 6-month naturalistic study of outcome in schizophrenic outpatients, treated with olanzapine.Hum Psychopharmacol. 2011 Jan;26(1):81-5. doi: 10.1002/hup.1173. Epub 2011 Feb 9. Hum Psychopharmacol. 2011. PMID: 23055416 Review.
-
Neurotoxicity and nephrotoxicity caused by combined use of lithium and risperidone: a case report and literature review.BMC Pharmacol Toxicol. 2016 Dec 14;17(1):59. doi: 10.1186/s40360-016-0101-x. BMC Pharmacol Toxicol. 2016. PMID: 27964751 Free PMC article. Review.
Cited by
-
A Pharmacovigilance Study on Psychotropic Agent-Induced Urinary Retention Using the Japanese Adverse Drug Event Report Database.Drugs Real World Outcomes. 2024 Nov 13. doi: 10.1007/s40801-024-00465-8. Online ahead of print. Drugs Real World Outcomes. 2024. PMID: 39537981
-
Higher dose antiviral therapy for herpes infections is associated with a risk of serious adverse events in older adults with chronic kidney disease.Pharmacol Res Perspect. 2024 Dec;12(6):e70028. doi: 10.1002/prp2.70028. Pharmacol Res Perspect. 2024. PMID: 39428714 Free PMC article.
-
Risk of renal impairment in atypical antipsychotics: a systematic review and meta-analysis.Eur J Clin Pharmacol. 2024 Oct;80(10):1435-1444. doi: 10.1007/s00228-024-03714-5. Epub 2024 Jun 25. Eur J Clin Pharmacol. 2024. PMID: 38916726
-
Multiple adverse outcomes associated with antipsychotic use in people with dementia: population based matched cohort study.BMJ. 2024 Apr 17;385:e076268. doi: 10.1136/bmj-2023-076268. BMJ. 2024. PMID: 38631737 Free PMC article.
-
High-Throughput Computing to Automate Population-Based Studies to Detect the 30-Day Risk of Adverse Outcomes After New Outpatient Medication Use in Older Adults with Chronic Kidney Disease: A Clinical Research Protocol.Can J Kidney Health Dis. 2024 Jan 6;11:20543581231221891. doi: 10.1177/20543581231221891. eCollection 2024. Can J Kidney Health Dis. 2024. PMID: 38186562 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources